Objectives: 15-16 and 7

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/53

encourage image

There's no tags or description

Looks like no tags are added yet.

54 Terms

1
New cards

What are Acute Leukemias?

  • malignant disease of hematopoietic tissue, characterized by replacement of normal bone marrow elements with neoplastic blood cells


2
New cards

What are features of Acute Leukemia?

  • age: all ages

  • onset: sudden

  • course (untreated): < 6 months

  • Leukemic cells: immature

  • anemia: mild-severe

  • thrombocytopenia: mild-severe

  • WBC count: variable

  • organomegaly: mild


3
New cards

What is the main cytochemistry finding that indicates ALL

  • negative peroxidase and sudan Black B


4
New cards

What is the main cytochemistry finding that indicates AML

  • positive peroxidase and sudan black-B

    • positive for myeloid cells


5
New cards

What is Myeloperoxidase (MPO)

  • detects enzyme myeloperoxidase, which is found in granules of myeloid cells

  • used to identify myeloid differentiation

  • positive MPO strongly supports AML

    • rules out ALL


6
New cards

What are the results of Myeloperoxidase (MPO) stain?

  • Peroxidase is present in granules of myeloid cells

  • Promyelocytes/ seg neutrophils: pos

  • Eosinophils: pos

  • Monocytes: weak pos

  • RBC precursors / lymphs: neg

  • positive in myeloid cells

  • POSITIVE MPO rules out ALL


7
New cards

What does Sudan Black B (SBB) stain do?

  • detects fats and lipids within cells

  • stains graules of myeloid cells

  • Positive SBB supports AML

    • rules out ALL


8
New cards

What are the results of Sudan Black (SBB) stain?

  • fats/lipids: pos

  • mature segmented neutrophils: pos

  • eosinophils: pos

  • monocytes: variable

  • lymphocytes: negative

  • myeloid cells: pos

  • POS SBB rules out ALL


9
New cards

What is naphthol AS-D Chloroacetate (NASDA) esterase stain?

  • identifies granulocytic differentiation

  • neutrophils and their precursors stain positive

  • monocytes and lymphocytes stain negative


10
New cards

What happens in naphthol AS-D Chloroacetate (NASDA) esterase s

  • neutrophils/precursors: pos

  • monocytes/lymphocytes: neg

  • good for myeloid differentiation (granulocytes)


11
New cards

Describe Alpha-nephthl butryate esterase.

  • identifes monocytic differentiation

  • enzyme is found in:

    • monocytes

    • macrophages

    • T lymphocytes


12
New cards

Describe Acid Phosphatase stain.

  • produces red color in granules

  • found in all hematopoietic cells, highest level in: macrophages/osteoclasts


13
New cards

What happens in Acid Phosphatase stain?

  • monocytes: pos

  • neutrophils / precursors: weak pos

  • lymphocytes: pos

  • reaction can be inhibited by tartrate

    • TRAP is an isoenzyme found in lymphoid cells of hair cell leukemia


14
New cards

Describe PAS (periodic acid-schiff)

  • detects glycogen and carbohydrates in the cytoplasm

  • positive reaction produces a red color


15
New cards

What happens in PAS stain?

  • erythroblasts - pos

  • monocytes - faint staining

  • lymphocytes - few pos granules in ALL

  • lymphoblasts may show coars block pattern of activity

  • megakaryocytes - pos


16
New cards

Describe TRAP stain.

  • stain cells with acid phosphatase

  • in most cells the red color disappears

  • in Hairy cell leukemia → red color persists due to tartrate-resistant isoenzyme

  • primarily associated with hairy cell leukemia rather than AML


17
New cards

What is associated with Prefibrotic Primary Myelofibrosis (PMF)?

  • myeloproliferative of WBCs and megakaryocytes

  • atypical megakaryocytes

  • no BM fibrosis

  • increased megakaryocytes

  • PB:

    • immature granulocytes / normoblasts

    • tear drop cells

  • increased collagen due to increased PDGF (plt derived growth factor)


18
New cards

What is associated with Fibrotic Primary Myelofibrosis (PMF)?

  • BM fibrosis

  • Immature WBCs

  • nRBCs


19
New cards

What are the major criteria of PrePMF?

  • megakaryocyte proliferation without reticulin fibrosis > grade 1 with increased age-adjusted BM cellularity, granulocytic proliferation, decreased erythropoiesis

  • not meeting WHO criteria for BRC-ABL1, CML, PV, ET, MDS

  • presence of JAK2,CALR,MPL mutation or absence of these, presence of another clonal marker or absence of minor reactive BM reticulin fibrosis


20
New cards

What are the minor criteria of PrePMF?

  • anemia not attributed to a comorbid condition

  • Leukocytosis > 11 × 10^9/L

  • palpable splenomegaly

  • LDH> above upper limit


21
New cards

What is needed to diagnoseprePMF?

  • all 3 major criteria + 1 minor criteria


22
New cards

What are the major criteria of Overt PMF?

  • presence of megakaryocyte proliferation accompanied by either reticulin and/or collagen fibrosis grade 2 or 3

  • not meeting WHO criteria for ET,PV, BRC-ABL1, CML, MDS

  • presence of JAK2,CALR,MPL mutation or in absence of these, presence of another clonal marker, or absence of reactive myelofibrosis


23
New cards

What are the minor criteria of Overt PMF?

  • anemia not attributed to a comorbid condition

  • leukocytosis > 11 × 10^9/L

  • palpable splenomegaly

  • LDH > upper limit

  • Leukoblastosis


24
New cards

What is needed to diagnose Overt PMF?

  • meets all 3 major criteria + 1 minor


25
New cards

What AML subtype patches this description?

  • routine cytochemical stains negative

  • SBB, MPO, and esterases negative


  • M0 - minimally differentiated


26
New cards

What AML subtype patches this description?

  • MPO positive


  • M1 - without maturation


27
New cards

What AML subtype patches this description?

  • MPO positive

  • Auer rods may be present


  • M2 - with maturation


28
New cards

What AML subtype patches this description?

  • MPO+

  • SBB+

  • NASDA+

  • abundant granules + Auer rods


  • M3 - Acute promyelocytic leukemia (APL)


29
New cards

What AML subtype patches this description?

  • both granulocytic + monocytic differentiation


  • M4 - Acute myelomonocytic leukemia


30
New cards

What AML subtype patches this description?

  • monocytic differentiation

  • alpha-naphthyl butyrate esterase helps identify monocytic cells


  • M5 - Acute monocytic leukemia


31
New cards

What AML subtype patches this description?

  • PAS positive

  • Abnormal erythroid precusors


  • M6 - Acute erythroid leukemia


32
New cards

What AML subtype patches this description?

  • Megakaryocytic differentiation

  • identified with markers:

    • CD41, CD42b, CD61


  • M7 - Acute Megakaryoblastic Leukemia


33
New cards
<p>Describe <strong>AML-M0</strong></p>

Describe AML-M0

  • BM > 30% blasts

  • lack evidence of differentiation

  • no Auer rods

  • SBB-, MPO-, NASDA-

  • CD13+, CD33+, CD34+


34
New cards
<p>Describe <strong>AML-M1</strong></p>

Describe AML-M1

  • myeloblasts usually predominate in BM with minimal maturation

  • MPO +


35
New cards
<p>Describe <strong>AML-M2. </strong></p>

Describe AML-M2.

  • myeloid precursor cells of all stages found in BM

  • Auer rods present


36
New cards
<p>Describe <strong>AML-M3-APL</strong></p>

Describe AML-M3-APL

  • promyelocytes predominate

  • abundance of azurophilic granules

  • Auer rods present

  • correlation to DIC

  • t(15;17)

  • SBB+, MPO+, NASDA+


37
New cards
<p>Describe <strong>AML-M4</strong></p>

Describe AML-M4

  • monocytic and granulocytic precursor cells


38
New cards
<p>Describe <strong>AML-M5a</strong></p>

Describe AML-M5a

  • monocytic leukemia

  • poorly differentiated

  • 1-2 nucleoli


39
New cards
<p>Describe <strong>AML-M5b</strong></p>

Describe AML-M5b

  • differentiated monocytic cells

    • monoblasts, promonocytes, monocytes

  • Low N:C


40
New cards
<p>Describe <strong>AML-M6</strong></p>

Describe AML-M6

  • abnormal erythroid precursors predominate

  • Bizarre nuclear shapes

  • Multinucleated giant forms

  • vacuoles in cytoplasm

  • may have Auer rods

  • Myeloblasts increased

  • PAS+


41
New cards
<p>Describe <strong>AML-M7</strong></p>

Describe AML-M7

  • > 20% of megakaryocytes and megakaryoblasts in Bm with increase in reticulum fibers, fibrotic growth

  • children with Down Syndrome

  • Giant PLTs seen


42
New cards

What major classification systems are used to classify acute leukemias?

  • FAB (French-American-British)

    • distinguishes lymphoblasts from myeloblasts

    • morphological / cytochemical characterization

    • divides AML into M0-M7 and ALL into L1 and L3

  • WHO (World Health Organization)


43
New cards
<p>Describe <strong>FAB ALL-L1</strong></p>

Describe FAB ALL-L1

  • morphology

    • small, monotonous lymphocytes, scant cytoplasm

    • high nuclear to cytoplasmic ratio

  • features:

    • uniform size, no prominent nucleoli

  • clinical features

    • common in childhood


44
New cards
<p>Describe <strong>FAB ALL-L2</strong></p>

Describe FAB ALL-L2

  • morphology

    • large, heterogenous lymphoblasts, variable size/shape

  • features

    • mixed L1-L3 type features, more cytoplasm than L1

    • irregular nuclear contours

  • clinical note

    • common in adult ALL


45
New cards
<p>Describe <strong>FAB ALL-L3</strong></p>

Describe FAB ALL-L3

  • morphology

    • large, uniform blast cells, abundant cytoplasm + vacuoles

  • features

    • “stary sky” appearance, vacuoles represent lipid droplets

    • associated with Burkitt lymphoma

  • clinical note

    • rare in ALL


46
New cards

What is in the WHO classification for ALL?

  • B lymphoblastic leukemia/lymphoma t(9;22)(q34.1;q11.2);BCR-ABL1

  • B lymphoblastic leukemia/lymphoma t(v;11q23.3);KMT2A rearranged

  • B lymphoblastic leukemia/lymphoma t(12;21)(p13.2;q22.1);ETV6-RUNX1

  • B lymphoblastic leukemia/lymphoma with hyperdiploidy

  • B lymphoblastic leukemia/lymphoma with hypodiploidy

  • B lymphoblastic leukemia/lymphoma t(5;14)(q31.1;q32.3) IL3-IGH

  • B lymphoblastic leukemia/lymphoma t(1;19)(q23;p13.3);TCF3-PBX1


47
New cards

Describe B lymphoblastic leukemia/lymphoma:

  • t(9;22)(q34.1;q11.2);BCR-ABL1


  • t(9;22)

  • children / adults

  • poorer prognosis

  • immunophenotyping

    • CD10+, CD19+, CD34+

  • treatment: chemo


48
New cards

Describe B lymphoblastic leukemia/lymphoma:

  • t(v;11q23.3);KMT2A rearranged


  • t(11q23.3)

  • CNS involvement, organomegaly

  • occurs in utero / after birth

  • immunophenotyping

    • CD10-, CD15, CD19+, CD24-

  • treatment: chemo


49
New cards

Describe B lymphoblastic leukemia/lymphoma:

  • t(12;21)(p13.2;q22.1);ETV6-RUNX1


  • 20-30% of childhood preB ALL

  • good prognosis, 90% remissions

  • t(12,21)

  • immunophenotyping

    • CD10+, CD19+, HLA-DR+,CD13+, CD33+

    • CD9-, CD20-


50
New cards

Describe B lymphoblastic leukemia/lymphoma:

  • with hyperdiploidy


  • affects 25-33% of children (age 3-5), 5% of adults with B-ALL, not seen in infants

  • favorable prognosis

  • extra chromsomes: 4,6,17

  • blasts contain> 50 chromosomes, usually without transolocations

  • immunophenotype:

    • CD19+, CD10+, CD34+, CD45-


51
New cards

Describe B lymphoblastic leukemia/lymphoma:

  • with hypodiploidy


  • neoplasm of blasts committed to B cell lineage

  • comprises 5% of all ALL

  • blasts contain < 46 chromosomes

  • poor prognosis

    • except if patient has 44-45 chromosomes

  • immunophenotyping

    • CD10+, CD19+

  • treatment: chemo


52
New cards

Describe B lymphoblastic leukemia/lymphoma:

  • t(5;14)(q31.1;q32.3) IL3-IGH


  • Neoplasm of Blasts committed to B cell lineage

  • translocation between IL3 and IgH gene

  • variable eosinophilia

  • affects children / adults

  • < 1% ALL

  • immunophenotyping

    • CD10+, CD19+

  • treatment: chemo


53
New cards

Describe B lymphoblastic leukemia/lymphoma:

  • t(1;19)(q23;p13.3);TCF3-PBX1


  • neoplasm with blasts of B cell lineage

  • translocation between TCF3 on chromosome 19 and PBX1 on chromosome 1

  • more common in children than adults

  • 6% of all B-ALL

  • immunophenotyping

    • CD9+, CD10+, CD19+, CD34-


54
New cards

Describe T-ALL

  • 15-25% of patients with ALL

  • immunophenotype: CD7+, CD5+, CD2+, TdT+

  • CD4 and CD8 can be coexpressed

  • high WBC count > 100 × 10^9/L in 50% of cases

  • M>F

  • mass in chest area possible